October 19, 2022
Agreement grants Eterna rights to license up to four next-generation iPS cell derived NK and T cell cancer therapies License terms include an upfront license […]
August 3, 2022
Phase 2 clinical trial for OXE103 for the treatment of concussion is being conducted at University of Kansas Medical Center, Kansas City, Kansas Enrolling highly […]
February 2, 2022
Genetic Engineering & Biotechnology News – Bitter Taste Receptors Represent a Therapeutic Sweet Spot
Stimulating bitter taste receptors, the body’s early warning system for toxic substances, can fight obesity and inflammation. By Gail Dutton – February 02, 2022 Bitter […]
February 2, 2022
Two studies evaluate ARD-101 in Obesity: one in General Obesity and the other in Refractory Weight Gain Post-Bariatric Surgery. The 3rd clinical trial is in […]